5VSH
CH1/Clambda Fab based on Pertuzumab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 31-ID |
Synchrotron site | APS |
Beamline | 31-ID |
Temperature [K] | 77 |
Detector technology | CCD |
Collection date | 2015-04-22 |
Detector | RAYONIX MX225HE |
Wavelength(s) | 0.97931 |
Spacegroup name | C 1 2 1 |
Unit cell lengths | 137.531, 106.207, 156.772 |
Unit cell angles | 90.00, 117.48, 90.00 |
Refinement procedure
Resolution | 25.700 - 2.550 |
R-factor | 0.209 |
Rwork | 0.206 |
R-free | 0.25520 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1l7i |
RMSD bond length | 0.008 |
RMSD bond angle | 1.040 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | BUSTER (2.11.5) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 25.700 | 2.690 |
High resolution limit [Å] | 2.550 | 2.550 |
Rmerge | 0.138 | 0.527 |
Number of reflections | 60826 | 8443 |
<I/σ(I)> | 6.5 | 2 |
Completeness [%] | 93.1 | 89.2 |
Redundancy | 3.6 | 3.6 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 294 | see publication |